Indication
Prevention of deep vein thrombosis recurrence
Prevention of deep vein thrombosis recurrence refers to the secondary prophylactic management of patients with a documented history of deep vein thrombosis to avert subsequent occlusive thromboembolic events. Read more about Prevention of deep vein thrombosis recurrence
0 drugs 0 manufacturers
Drugs that treat it
Common Prevention of deep vein thrombosis recurrence therapies.
No drugs are available
This indication does not currently contain public drugs.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPrevention of deep vein thrombosis recurrence refers to the secondary prophylactic management of patients with a documented history of deep vein thrombosis to avert subsequent occlusive thromboembolic events.
The condition primarily impacts the deep venous vasculature—most frequently within the lower extremities, pelvis, or upper limbs—where residual endothelial damage, abnormal venous hemodynamics, or persistent prothrombotic states increase susceptibility to new clot formation.
It is pathophysiologically characterized by the reactivation of intravascular coagulation cascades, intraluminal fibrin mesh deposition, and potential vessel occlusion, presenting risks of painful limb swelling, chronic venous insufficiency, or life-threatening pulmonary embolization.
- nih.gov
Prevention of deep vein thrombosis recurrence refers to the secondary prophylactic management of patients with a documented history of deep vein thrombosis to avert subsequent occlusive thromboembolic events The condition primarily impacts the deep venous vasculature—most frequently within the lower extremities, pelvis, or upper limbs—where residual endothelial damage, abnormal venous hemodynamics, or persistent prothrombotic states increase susceptibility to new clot formation It is pathophysio...
- pfizer.com
Prevention of deep vein thrombosis recurrence refers to the secondary prophylactic management of patients with a documented history of deep vein thrombosis to avert subsequent occlusive thromboembolic events
- nih.gov
Prevention of deep vein thrombosis recurrence refers to the secondary prophylactic management of patients with a documented history of deep vein thrombosis to avert subsequent occlusive thromboembolic events
- nih.gov
The condition primarily impacts the deep venous vasculature—most frequently within the lower extremities, pelvis, or upper limbs—where residual endothelial damage, abnormal venous hemodynamics, or persistent prothrombotic states increase susceptibility to new clot formation
- medlineplus.gov
The condition primarily impacts the deep venous vasculature—most frequently within the lower extremities, pelvis, or upper limbs—where residual endothelial damage, abnormal venous hemodynamics, or persistent prothrombotic states increase susceptibility to new clot formation
- nih.gov
It is pathophysiologically characterized by the reactivation of intravascular coagulation cascades, intraluminal fibrin mesh deposition, and potential vessel occlusion, presenting risks of painful limb swelling, chronic venous insufficiency, or life-threatening pulmonary embolization
- ccjm.org
It is pathophysiologically characterized by the reactivation of intravascular coagulation cascades, intraluminal fibrin mesh deposition, and potential vessel occlusion, presenting risks of painful limb swelling, chronic venous insufficiency, or life-threatening pulmonary embolization
Personalize your experience
Follow Prevention of deep vein thrombosis recurrence and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.